A61K 9/0002
Galenical forms characterised by the drug release technique
Official title: {Galenical forms characterised by the drug release technique; Application systems commanded by energy}
A61K9/0002 (Galenical forms characterised by the drug release technique) appears on 2,869 US grants and 4,098 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,869
- Published applications
- 4,098
- Assignees
- 1,623
- Inventors
- 6,386
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 12 | 0 |
| 1978 | 15 | 0 |
| 1979 | 11 | 0 |
| 1980 | 9 | 0 |
| 1981 | 14 | 0 |
| 1982 | 10 | 0 |
| 1983 | 4 | 0 |
| 1984 | 14 | 0 |
| 1985 | 8 | 0 |
| 1986 | 20 | 0 |
| 1987 | 28 | 0 |
| 1988 | 26 | 0 |
| 1989 | 41 | 0 |
| 1990 | 41 | 0 |
| 1991 | 42 | 0 |
| 1992 | 38 | 0 |
| 1993 | 61 | 0 |
| 1994 | 33 | 0 |
| 1995 | 29 | 0 |
| 1996 | 33 | 0 |
| 1997 | 56 | 0 |
| 1998 | 64 | 0 |
| 1999 | 69 | 0 |
| 2000 | 46 | 0 |
| 2001 | 65 | 33 |
| 2002 | 53 | 93 |
| 2003 | 65 | 116 |
| 2004 | 43 | 138 |
| 2005 | 40 | 164 |
| 2006 | 35 | 124 |
| 2007 | 23 | 170 |
| 2008 | 26 | 160 |
| 2009 | 41 | 145 |
| 2010 | 56 | 162 |
| 2011 | 75 | 187 |
| 2012 | 109 | 164 |
| 2013 | 116 | 273 |
| 2014 | 126 | 158 |
| 2015 | 144 | 220 |
| 2016 | 134 | 192 |
| 2017 | 140 | 195 |
| 2018 | 104 | 178 |
| 2019 | 122 | 183 |
| 2020 | 107 | 200 |
| 2021 | 117 | 174 |
| 2022 | 83 | 174 |
| 2023 | 86 | 167 |
| 2024 | 91 | 130 |
| 2025 | 75 | 127 |
| 2026 | 56 | 71 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Delayed release compositions22 Sep 2026US 12,740,951 B2Amneal Complex Products Research LLC
- Clinical dosing schedule of inositol phosphate oligo(ethylene glycol) compounds15 Sep 2026US 12,734,184 B2Vifor (International) AG
- ABCD1 for treatment of neurodisorders15 Sep 2026US 12,735,706 B2The General Hospital Corporation
- Delayed release oral pharmaceutical composition8 Sep 2026US 12,728,097 B2Aihol Corporation
- Transdermal patch of a portable ultrasound-generating system for improved delivery of therapeutic agents and associated methods of treatment8 Sep 2026US 12,728,102 B2NanoVibronix Inc
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Pharmaceutical composition comprising ibuprofen1 Oct 2026US 2026/0294855 A1
- Treatment of pancreatic cancer17 Sep 2026US 2026/0272821 A1Exact Therapeutics AS
- Targeting Microbubbles17 Sep 2026US 2026/0273061 A1California Institute of Technology
- Delayed timed release pharmaceutical composition, preparation method therefor, and use thereof10 Sep 2026US 2026/0263349 A1Shanghai Wd Pharmaceutical Co., Ltd
Most cited
By later US patents
- Osmotic device with hydrogel driving member1,628US 4,327,725 AAlza Corporation · 1982
- Means for providing instant agent from agent dispensing system1,381US 4,643,731 AAlza Corporation · 1987
- Low-permeability, laser-activated drug delivery device1,367US 8,911,426 B2On Demand Therapeutics, Inc. · 2014
- Osmotic system having laminar arrangement for programming delivery of active agent1,023US 4,008,719 AAlza Corporation · 1977
- Dispensing device containing a hydrophobic medium820US 5,431,921 APfizer Inc. · 1995